Podak Co Ltd
TPEX:3537
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Podak Co Ltd
TPEX:3537
|
TW |
|
Sangamo Therapeutics Inc
OTC:SGMO
|
US |
|
Immolease Trust NV
XBRU:DIEG
|
BE |
|
Wallbridge Mining Company Ltd
TSX:WM
|
CA |
|
P
|
Pacific Energy & Mining Co
OTC:PEMC
|
US |
|
T
|
Texwinca Holdings Ltd
XMUN:TXW
|
HK |
|
Anthera Pharmaceuticals Inc
OTC:ANTH
|
US |
|
C
|
Comeco SA
WSE:CMC
|
PL |
|
S
|
Saltire Capital Ltd
OTC:SLTEF
|
CA |
|
Avensia AB
F:5IY
|
SE |
|
F
|
Falcon Metals Ltd
ASX:FAL
|
AU |
|
Seiren Co Ltd
F:1AB
|
JP |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Podak Co Ltd's stock price target?
Not Available
Podak Co Ltd does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Podak Co Ltd?
Projected CAGR
-1%
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 7 years is -1%.
What is the Gross Profit forecast for Podak Co Ltd?
Projected CAGR
-1%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 7 years is -1%.
What is the Operating Income forecast for Podak Co Ltd?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 7 years is -2%.
What is the Pre-Tax Income forecast for Podak Co Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 7 years is 1%.
What is the Net Income forecast for Podak Co Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 7 years is 1%.